Cargando…

Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021

This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices.

Detalles Bibliográficos
Autores principales: Tabak, Ying P., Sun, Xiaowu, Brennan, Troyen A., Chaguturu, Sreekanth K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696565/
https://www.ncbi.nlm.nih.gov/pubmed/34935923
http://dx.doi.org/10.1001/jamanetworkopen.2021.43346
_version_ 1784619843354361856
author Tabak, Ying P.
Sun, Xiaowu
Brennan, Troyen A.
Chaguturu, Sreekanth K.
author_facet Tabak, Ying P.
Sun, Xiaowu
Brennan, Troyen A.
Chaguturu, Sreekanth K.
author_sort Tabak, Ying P.
collection PubMed
description This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices.
format Online
Article
Text
id pubmed-8696565
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-86965652022-01-10 Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021 Tabak, Ying P. Sun, Xiaowu Brennan, Troyen A. Chaguturu, Sreekanth K. JAMA Netw Open Research Letter This case-control study evaluates the estimated vaccine effectiveness against infection changes over time to help inform public health policy and clinical practices. American Medical Association 2021-12-22 /pmc/articles/PMC8696565/ /pubmed/34935923 http://dx.doi.org/10.1001/jamanetworkopen.2021.43346 Text en Copyright 2021 Tabak YP et al. JAMA Network Open. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the CC-BY-NC-ND License.
spellingShingle Research Letter
Tabak, Ying P.
Sun, Xiaowu
Brennan, Troyen A.
Chaguturu, Sreekanth K.
Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title_full Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title_fullStr Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title_full_unstemmed Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title_short Incidence and Estimated Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Among Persons Tested in US Retail Locations, May 1 to August 7, 2021
title_sort incidence and estimated vaccine effectiveness against symptomatic sars-cov-2 infection among persons tested in us retail locations, may 1 to august 7, 2021
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8696565/
https://www.ncbi.nlm.nih.gov/pubmed/34935923
http://dx.doi.org/10.1001/jamanetworkopen.2021.43346
work_keys_str_mv AT tabakyingp incidenceandestimatedvaccineeffectivenessagainstsymptomaticsarscov2infectionamongpersonstestedinusretaillocationsmay1toaugust72021
AT sunxiaowu incidenceandestimatedvaccineeffectivenessagainstsymptomaticsarscov2infectionamongpersonstestedinusretaillocationsmay1toaugust72021
AT brennantroyena incidenceandestimatedvaccineeffectivenessagainstsymptomaticsarscov2infectionamongpersonstestedinusretaillocationsmay1toaugust72021
AT chaguturusreekanthk incidenceandestimatedvaccineeffectivenessagainstsymptomaticsarscov2infectionamongpersonstestedinusretaillocationsmay1toaugust72021